ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 52 filers reported holding ADC THERAPEUTICS SA in Q4 2020. The put-call ratio across all filers is 5.38 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $425,000 | -34.2% | 28,949 | -9.5% | 0.01% | -52.9% |
| Q4 2021 | $646,000 | -45.0% | 32,000 | -26.0% | 0.02% | -22.7% |
| Q3 2021 | $1,175,000 | +12.2% | 43,258 | +0.6% | 0.02% | +15.8% |
| Q2 2021 | $1,047,000 | +296.6% | 43,017 | +421.3% | 0.02% | +280.0% |
| Q4 2020 | $264,000 | -75.2% | 8,252 | -74.4% | 0.01% | -84.4% |
| Q3 2020 | $1,063,000 | -12.2% | 32,230 | +24.5% | 0.03% | -44.8% |
| Q2 2020 | $1,211,000 | – | 25,878 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vantage Consulting Group Inc | 1,186,215 | $5,718,000 | 3.34% |
| Blue Owl Capital Holdings LP | 733,568 | $3,536,000 | 1.53% |
| Redmile Group, LLC | 7,512,029 | $36,208,000 | 1.40% |
| GCM Grosvenor Holdings, LLC | 735,471 | $3,545,000 | 0.84% |
| Prosight Management, LP | 247,630 | $1,194,000 | 0.64% |
| Indie Asset Partners, LLC | 93,839 | $452,000 | 0.46% |
| MPM BioImpact LLC | 334,384 | $1,612,000 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,390,297 | $11,521,000 | 0.23% |
| Eventide Asset Management | 1,879,959 | $9,061,000 | 0.18% |
| APOGEM CAPITAL LLC | 17,405 | $84,000 | 0.08% |